Jeffrey T. Walsh, Chief Strategy Officer at bluebird bio, Inc. (BLUE), sold 1,900 shares at $157.23 ($298K) on 2019-04-10, disclosed to the SEC on 2019-04-12.
Open-market sale of $298k BLUE by Chief Strategy Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.44 | 1,100 | $172K | 57.8% |
| 2 | $157.23 | 400 | $63K | 21.1% |
| 3 | $157.23 | 400 | $63K | 21.1% |
| Total | $156.77 avg | 1,900 | $298K | 100% |
| Filing → |
| BLUE | SELL | 2019-06-12 | $176K | — | Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-03-13 | $419K | — | Filing → |